You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
On June 8, Novo Nordisk announced the Food and Drug Administration approved insulin aspart (NovoLog), its new rapid-acting insulin analogue.
According to Novo, NovoLog has faster absorption, faster onset of action and shorter duration of action than Regular human insulin, allowing people with diabetes to inject themselves immediately before eating.
"NovoLog will add the option of another fine Novo Nordisk product to the treatment choice for Americans with diabetes and will complement our range of therapeutics and medical devices such as NovoPen3,'' said Bill Poole, president of Novo Nordisk.
NovoLog is sold as NovoRapid outside the United States Novo Nordisk received marketing approval for NovoRapid from the European Union last year, and it is now available in several European countries, including the United Kingdom and Germany.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.